STYK1 and neoplasm: Serine-threonine tyrosine kinase 1 (STYK1), also known as a novel oncogene with kinase domain (NOK), belongs to the receptor protein tyrosine kinases (RPTKs) subfamily [115], and has a strong ability to promote tumor formation and metastatic capacity [116].